NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 168 filers reported holding NOVOCURE LTD in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $829,000 | +10.4% | 10,000 | 0.0% | 0.79% | +59.5% |
Q4 2021 | $751,000 | -35.4% | 10,000 | 0.0% | 0.50% | -20.3% |
Q3 2021 | $1,162,000 | -47.6% | 10,000 | 0.0% | 0.62% | -53.1% |
Q2 2021 | $2,218,000 | +67.8% | 10,000 | 0.0% | 1.33% | +37.3% |
Q1 2021 | $1,322,000 | -23.6% | 10,000 | 0.0% | 0.97% | -44.0% |
Q4 2020 | $1,730,000 | +55.4% | 10,000 | 0.0% | 1.72% | +38.7% |
Q3 2020 | $1,113,000 | +87.7% | 10,000 | 0.0% | 1.24% | +13.8% |
Q2 2020 | $593,000 | -11.9% | 10,000 | 0.0% | 1.09% | -28.2% |
Q1 2020 | $673,000 | -20.2% | 10,000 | 0.0% | 1.52% | -40.3% |
Q4 2019 | $843,000 | +12.7% | 10,000 | 0.0% | 2.55% | +112.4% |
Q3 2019 | $748,000 | -40.9% | 10,000 | -50.0% | 1.20% | -44.2% |
Q2 2019 | $1,265,000 | +31.4% | 20,000 | 0.0% | 2.15% | +159.7% |
Q1 2019 | $963,000 | -28.1% | 20,000 | -50.0% | 0.83% | -20.8% |
Q4 2018 | $1,339,000 | -89.4% | 40,000 | -83.3% | 1.04% | -84.7% |
Q3 2018 | $12,576,000 | +46.1% | 240,000 | -12.7% | 6.81% | +5.9% |
Q2 2018 | $8,608,000 | +43.6% | 275,000 | 0.0% | 6.43% | +40.6% |
Q1 2018 | $5,995,000 | +196.8% | 275,000 | +175.0% | 4.57% | +216.5% |
Q4 2017 | $2,020,000 | +35.7% | 100,000 | +33.3% | 1.44% | +45.1% |
Q3 2017 | $1,489,000 | -42.6% | 75,000 | -50.0% | 1.00% | -25.3% |
Q2 2017 | $2,595,000 | -32.8% | 150,000 | -68.5% | 1.33% | -58.0% |
Q1 2017 | $3,861,000 | -1.6% | 476,717 | -4.7% | 3.18% | +30.7% |
Q4 2016 | $3,925,000 | -8.1% | 500,000 | 0.0% | 2.43% | +47.6% |
Q3 2016 | $4,270,000 | – | 500,000 | – | 1.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |